Figure 2From: The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes populationStudy design and randomization to intervention arms. Eighty T2D or metabolic syndrome subjects were recruited into the double-blind, parallel intervention study and 71 were randomized to the three intervention arms. Fifty-nine subjects completed the study (74%). The reasons for withdrawals are shown for each arm.Back to article page